ArticleOncology reports2022

Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer.

Tomokatsu Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.